In hepatocellular carcinoma (HCC), a newly identified HBV-miRNA (HBV-miR-2) serves as a tumor-suppressor and an oncogenic miRNA by inhibiting Tripartite Motif Containing 35 (TRIM35) and targeting Ras-related nuclear protein (RAN). This evidence concerns the gene RAN and hepatocellular carcinoma.